Chantix Suicide Lawsuits Mount Against Pfizer - AboutLawsuits.com

Three new Chantix lawsuits were filed last week in New York state court against Pfizer, Inc., the manufacturer of the popular smoking cessation drug. The cases were filed on behalf of individuals who claim that side effects of Chantix caused users to ...

Chantix Update: The Good, the Bad and the Ugly - Lawyers and Settlements

Jacksonville, OR: There has been much development on the Chantix portfolio in recent months that speaks to the Jekyll-and-Hyde personality of the smoking cessation drug introduced by Pfizer in 2006. Released amidst much fanfare and embraced by smokers ...

FDA: Chantix Benefits Still Outweigh the Risks - MedicineNet.com

Oct. 24, 2011 -- New studies show that the benefits of the stop-smoking drug Chantix still outweigh its risks, the FDA says. The FDA-sponsored studies find that Chantix does not increase a person's risk of psychiatric hospitalization. But the studies "do ...

Chantix Risks Do Not Include Heart Attacks, Heart Problems: Report - AboutLawsuits.com

A new review of prior clinical trial data suggests that side effects of Chantix do not appear to increase the risk of heart attacks or other heart problems, contradicting the findings of a study published last year involving the popular stop-smoking drug.

Chantix May Help Heavy Drinkers Cut Down - About - News & Issues

A drug used to help people stop smoking may also help heavy drinkers cut back the amount they drink, thereby reducing their harmful level of alcohol consumption. A study of the drug varenicline, marketed as Chantix, significantly reduced the ...

Unringing the Bell of Alarm on Varenicline - familypracticenews.com

Varenicline (Chantix) is arguably the most effective medication for the treatment of tobacco dependence. But as with many new medications, metaanalyses of published clinical data are conducted as both formal and informal components of postmarketing surveillance.

Chantix might not increase heart risk, review shows - SmartBrief

Pfizer's smoking-cessation treatment Chantix might not increase the risk of heart attack and other serious heart conditions, as was reported in a 2011 study, according to a review that looked at data on 9,232 people treated for three months. Researcher ...

America's Human Lab Rats - OpEdNews.com

No way, you say? The pharmaceutical industry partners with the U.S. government by using human lab rats. Chantix, the popular smoking cessation drug is back in the news as lawsuits against the drug maker mount in both state and federal courts. In 2008 ...

Scripps Gets $8 Million to Create Smoking Treatment; Could Help Coke Heads, Smack Addicts, and Obese People Too! - Broward New Times (blog)

But what about all those gums and patches? Or those drugs like Chantix? Kenny tells New Times that they're effective, but that their "level of effectiveness is very low." Also, Chantix and similar drugs carry some pretty severe side effects. There are even ...

Prior Analysis of Smoking-Cessation Drug’s Cardiovascular Safety was Misleading - YAHOO!

Varenicline, also known as Chantix, blocks the pleasant effects of nicotine on the smoker’s brain and lessens nicotine withdrawal symptoms. UCSF researchers, however, question the way the previous study was conducted, and their new analysis, published ...